CC BY-NC-ND 4.0 · Laryngorhinootologie 2019; 98(S 02): S83-S84
DOI: 10.1055/s-0039-1686080
Abstracts
Oncology

Development of a therapy decision-supporting system for laryngeal cancer based on Bayesian networks

M Stöhr
1   Universitätsklinik f. HNO-Heilkunde/Plast. Operationen, Leipzig
,
A Hikal
2   Innovation Center Computer Assisted Surgery, Leipzig
,
A Oeser
2   Innovation Center Computer Assisted Surgery, Leipzig
,
A Dietz
1   Universitätsklinik f. HNO-Heilkunde/Plast. Operationen, Leipzig
,
J Gaebel
2   Innovation Center Computer Assisted Surgery, Leipzig
,
H Lemke
3   Image Processing and Informatics Laboratory, Los Angeles, U.S.A.
,
M Cypko
2   Innovation Center Computer Assisted Surgery, Leipzig
› Author Affiliations
Bundesministerium für Bildung und Forschung
 

Introduction:

The increasing complexity of cancer diagnostics and more personalized treatment options, also in head and neck oncology, require new techniques of patient information processing and systems to support the decision-making process in the Head and neck tumor board (HN-TB). For this purpose, a digital patient model of larynx cancer (LC) based on Bayes ' networks (BN) was developed.

Methods:

The LC model was created according to accepted guidelines and analyses of HN-TBs. The subnetwork "TNM-State" was successfully validated before. Now the subnetwork "therapy" has been modeled and evaluated for primary treatment on the basis of 49 LC patient cases and compared with the HN-TB decisions of the University Hospital Leipzig.

Results:

The LC model contains over 1000 information entities, resulting it the most comprehensive human-readable BN model to represent a clinical decision. The subnet validation "therapy" revealed an initial match of 76% of the model computation compared to the therapy decision in the HN-TB. Further model optimization allowed for an improvement in correct model prediction.

Conclusions:

These analyses show, as proof of concept, that it is possible to model the therapy decision of LC on the basis of BN. Personalized medicine and targeted therapy are of increasing importance in oncologic therapy and require structured and comprehensive support of information management and decision-making. Further optimization and validation may allow digital patient models to provide valuable contribution to the diagnostics and therapy of head and neck carcinomas in the future.



Publication History

Publication Date:
23 April 2019 (online)

© 2019. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Stuttgart · New York